Ligand · LLN
LLN · (4~{a}~{S},8~{a}~{R})-2-cycloheptyl-4-[4-(2-hydroxyethyloxy)-3-[2-(2-oxidanylideneimidazolidin-1-yl)ethoxy]phenyl]-4~{a},5,8,8~{a}-tetrahydrophthalazin-1-one
LLN, (4~{a}~{S},8~{a}~{R})-2-cycloheptyl-4-[4-(2-hydroxyethyloxy)-3-[2-(2-oxidanylideneimidazolidin-1-yl)ethoxy]phenyl]-4~{a},5,8,8~{a}-tetrahydrophthalazin-1-one (C28 H38 N4 O5, 510.6 g/mol), in the MolNFT structures on GenesisL1: bound…
- Component
- LLN
- Formula
- C28 H38 N4 O5
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
LLN in 1 structure; the first of them:
- 5H2R · Crystal structure of T brucei phosphodiesterase B2 bound to compound 15b · LLN A1003 · binds TYR668, HIS669, THR783, MET785, ASP823, ILE824, ASN826, VAL827 and 12 more
Residues it binds most
VAL 2, MET 2, PHE 2, THR 2, ALA 2, ASN 2, ASP 2, GLN 2, GLY 2, HIS 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.